456 related articles for article (PubMed ID: 26601965)
1. Inflammatory Process in Alzheimer's and Parkinson's Diseases: Central Role of Cytokines.
Alam Q; Alam MZ; Mushtaq G; Damanhouri GA; Rasool M; Kamal MA; Haque A
Curr Pharm Des; 2016; 22(5):541-8. PubMed ID: 26601965
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
de Almeida EJR; Ibrahim HJ; Chitolina Schetinger MR; de Andrade CM; Cardoso AM
Neurochem Res; 2022 Nov; 47(11):3221-3240. PubMed ID: 35962936
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 4 regulates amyloid-β (Aβ)-induced neuroinflammation in Alzheimer's disease.
Li L; Zi X; Hou D; Tu Q
Neurosci Lett; 2017 Mar; 643():131-137. PubMed ID: 28189744
[TBL] [Abstract][Full Text] [Related]
6. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
Kaur D; Sharma V; Deshmukh R
Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
[TBL] [Abstract][Full Text] [Related]
7. [Pro-inflammatory cytokines in Alzheimer's disease].
Stamouli EC; Politis AM
Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
[TBL] [Abstract][Full Text] [Related]
8. Cytokines in neuroinflammation and Alzheimer's disease.
Cacquevel M; Lebeurrier N; Chéenne S; Vivien D
Curr Drug Targets; 2004 Aug; 5(6):529-34. PubMed ID: 15270199
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines.
Tanaka M; Toldi J; Vécsei L
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244523
[TBL] [Abstract][Full Text] [Related]
10. Inflammation: major denominator of obesity, Type 2 diabetes and Alzheimer's disease-like pathology?
Kacířová M; Zmeškalová A; Kořínková L; Železná B; Kuneš J; Maletínská L
Clin Sci (Lond); 2020 Mar; 134(5):547-570. PubMed ID: 32167154
[TBL] [Abstract][Full Text] [Related]
11. Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid beta peptide and interleukin-1beta.
Kim MS; Sung MJ; Seo SB; Yoo SJ; Lim WK; Kim HM
Neurosci Lett; 2002 Mar; 321(1-2):105-9. PubMed ID: 11872267
[TBL] [Abstract][Full Text] [Related]
12. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
13. The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.
Ramirez AI; de Hoz R; Salobrar-Garcia E; Salazar JJ; Rojas B; Ajoy D; López-Cuenca I; Rojas P; Triviño A; Ramírez JM
Front Aging Neurosci; 2017; 9():214. PubMed ID: 28729832
[TBL] [Abstract][Full Text] [Related]
14. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory Cytokines and Alzheimer's Disease: A Review from the Perspective of Genetic Polymorphisms.
Su F; Bai F; Zhang Z
Neurosci Bull; 2016 Oct; 32(5):469-80. PubMed ID: 27568024
[TBL] [Abstract][Full Text] [Related]
17. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease.
Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y
J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
19. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
Wang WY; Tan MS; Yu JT; Tan L
Ann Transl Med; 2015 Jun; 3(10):136. PubMed ID: 26207229
[TBL] [Abstract][Full Text] [Related]
20. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.
Blasko I; Veerhuis R; Stampfer-Kountchev M; Saurwein-Teissl M; Eikelenboom P; Grubeck-Loebenstein B
Neurobiol Dis; 2000 Dec; 7(6 Pt B):682-9. PubMed ID: 11114266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]